InfoBionic.Ai's CEO uncovered his own life-threatening arrhythmia his smartwatch missed, using the company's own MoMe ARC® system. His experience drives a new national awareness campaign on the urgent need for clinical-grade cardiac monitoring—especially for high-risk but asymptomatic individuals.
BOSTON, May 7, 2025 /PRNewswire-PRWeb/ -- Around 27% of people diagnosed with atrial fibrillation (AFib) experience no symptoms, and an estimated 2 million Americans may unknowingly live with this condition. (1, 2) Often called a "silent" disorder, AFib significantly increases the risk of stroke and doubles the chance of mortality. (3) Stuart Long, CEO of InfoBionic.AI, knows this all too well. During what should have been a routine training session, Long discovered he had a life-threatening arrhythmia his smartwatch couldn't detect. It was InfoBionic.AI's own MoMe ARC® cardiac monitoring system that identified the dangerous condition, leading to immediate hospitalization. Now, Long is on a mission to raise awareness about early cardiac detection, the limitations of consumer wearables, and the critical role of advanced monitoring technology in saving lives.
"The issue isn't just that patients and clinicians aren't looking—it's that they don't even know what they're missing," explains Stuart Long, CEO of InfoBionic.Ai. "Traditional systems offer glimpses. We offer full visibility."
Detecting a Hidden Arrhythmia: The Device That Changed Everything
Stuart Long had always believed his rigorous training and healthy lifestyle placed him among the least likely to encounter serious cardiac issues. But subtle discomfort during a workout unraveled that misconception. "It's not something you expect when you're in peak physical shape," says Long. Luckily, he had access to the MoMe ARC® system, a clinically precise cardiac monitoring platform his team had spent years perfecting. Within moments, the device detected the arrhythmia undetectable by his smartwatch, prompting an immediate intervention that, quite literally, saved his life.
The Reality of Wearables' Limitations
The scary truth? Consumer wearables like smartwatches and fitness trackers, despite their growing popularity and FDA-clearance for screening, simply aren't equipped for diagnostic-level insights. These devices rely on photoplethysmography (PPG) sensors, which often miss subtle or intermittent irregularities in heart activity. "Most wearables give you a partial picture, at best," explains Long. "They're built for lifestyle monitoring, not for catching life-threatening conditions." A recent Apple study reinforces this, showing that only 34% of users with irregular pulse notifications actually had AFib. (4) The rest? False alarms or missed diagnoses.
Infobionic's technology, on the other hand, sets a new standard. It captures every heartbeat, with full-disclosure ECG monitoring that doesn't compress or sample data. This 100% near real-time visibility ensures deadly conditions like Long's can no longer hide in the gaps.
The Overlooked Risk of Cardiac Stress in Athletes
Long's story isn't just a fluke; it's a warning. Atrial fibrillation (AFib), responsible for doubling the risk of strokes and increasing mortality, remains undiagnosed in millions of Americans. Alarmingly, it's an especially high-risk condition for endurance athletes. While regular exercise is good for the heart, the repetitive strain of long-term high-intensity training can amplify cardiac stress. Athletes often experience structural changes, including scarring and enlargement of the heart's atria, which increase their risk of arrhythmias.
"The problem is, as athletes, we chalk up fatigue or irregularities to overtraining," says Long. "But sometimes, it's your heart sending a warning signal." Without clinical-grade tools like, millions of those signals go unseen and untreated.
Empowering Early Detection Through Innovation
MoMe ARC® was designed to directly address these blind spots. Unlike devices like that screen for heart rate patterns using limited algorithms, this industry-defining platform provides diagnostic-grade data. It continuously streams full ECG waveforms, enabling clinicians to detect patterns or irregularities other systems might miss. Beyond detection, it expedites action with automated alerts, customizable thresholds, and direct communications to medical teams.
"This isn't just another device," Long asserts. "It's a game-changer for preventative cardiac care."
For someone like Long, it meant knowing when to act and having something no smartwatch has managed to offer yet: peace of mind backed by clinical precision.
Saving Lives Through Smarter Cardiac Monitoring Tools
Long's transformative experience is more than a personal achievement—it serves as a powerful call to action.Today, he's on a mission to ensure more Americans have access to life-saving tools like the MoMe ARC®. Through InfoBionic.AI's new national awareness campaign, the company is challenging outdated perceptions around cardiac health and exposing the significant gaps in current monitoring technologies.
"This is bigger than one person's story," Long says. "It's about changing how we think about preventative care, so fewer lives are lost to undetected conditions."
About InfoBionic.Ai
InfoBionic.Ai's digital technology has transformed the efficiency and economics of cardiac remote patient monitoring. The company's vision for its FDA-cleared third-generation platform, the MoMe ARC®, is to remove the roadblocks hindering virtual and remote diagnosis and decision-making. The Massachusetts-based team of seasoned entrepreneurs has had successful careers in healthcare, IT, medical devices, and mobile technology, and brings specific expertise in remote monitoring and cardiology. Visit https://infobionic.ai
References
1. Pamporis, Konstantinos, et al. "Prevalence of Asymptomatic Atrial Fibrillation and Risk Factors Associated with Asymptomatic Status: A Systematic Review and Meta-Analysis." European Journal of Preventive Cardiology, 7 Mar. 2025, academic.oup.com/eurjpc/advance-article/doi/10.1093/eurjpc/zwaf138/8063648, doi.org/10.1093/eurjpc/zwaf138.
2. Leighton-Seiffer, Harmony. "Could You Have AFib and Not Know It?" Hackensackmeridianhealth.org, 23 May 2024, hackensackmeridianhealth.org/en/healthu/2024/05/23/could-you-have-afib-and-not-know-it.
3. Cavallari, Ilaria, and Giuseppe Patti. "Early Risk of Mortality, Cardiovascular Events, and Bleeding in Patients with Newly Diagnosed Atrial Fibrillation." European Heart Journal Supplements: Journal of the European Society of Cardiology, vol. 22, 1 Nov. 2020, pp. L110–L113,
4. Perez, Marco V., et al. "Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation." New England Journal of Medicine, vol. 381, no. 20, 14 Nov. 2019, pp. 1909–1917, doi.org/10.1056/nejmoa1901183.
Media Inquiries:
Karla Jo Helms
JOTO PR™
727-777-4629
jotopr.com
Media Contact
Karla Jo Helms, JOTO PR™, 727-777-4629, [email protected], jotopr.com
SOURCE InfoBionic.Ai
Share this article